Oculomotor Nerve Palsy

Key Points at a Glance

Highlights of this disease

• Oculomotor nerve palsy is a condition caused by damage to the third cranial nerve, leading to ptosis, eye movement disorders, and pupillary abnormalities ¹.
• In adults, microvascular ischemia is the most common cause (approximately 42%), followed by trauma (approximately 12%), tumor compression (approximately 11%), postoperative (approximately 10%), and aneurysm (approximately 6%) ².
• When accompanied by pupillary dilation, it strongly suggests a posterior communicating artery aneurysm, which is a medical emergency requiring same-day imaging ¹³.
• Oculomotor nerve palsy without pupillary involvement is often ischemic, with approximately 95% achieving complete recovery, usually within three months ²⁴.
• It is important to differentiate from myasthenia gravis, thyroid eye disease, and internuclear ophthalmoplegia ³.
• Treatment prioritizes addressing the underlying cause; for aneurysms, urgent neurosurgical or endovascular treatment is required ⁶.

1. What is Oculomotor Nerve Palsy?

Oculomotor nerve palsy is an eye movement disorder caused by damage to the third cranial nerve (oculomotor nerve). The oculomotor nerve innervates the following muscles:

• Somatic extraocular muscles: medial rectus, superior rectus, inferior rectus, inferior oblique, and levator palpebrae superioris
• Autonomic nerves: pupillary sphincter and ciliary muscle (parasympathetic fibers)

These disorders result in a combination of ptosis, limited eye movement, pupillary dilation, and accommodation disturbance ¹³. Paralysis is classified as complete or partial (superior branch palsy, inferior branch palsy). Oculomotor nerve palsy is the second most common cranial nerve palsy.

In a population-based study in Olmsted County (Fang et al. 2017), the age- and sex-adjusted annual incidence was 4.0 per 100,000, rising to 12.5 in those aged 60 and older. The frequency of causes was reported as follows ².

Cause	Adults (Fang 2017) 2	Children (estimated) 1
Microvascular ischemia (diabetes, hypertension, etc.)	Approximately 42%	Rare
Trauma	Approximately 12%	Approximately 13–23%
Tumor compression	Approximately 11%	Approximately 10%
Post-surgical	Approximately 10%	—
Aneurysm compression	Approximately 6%	Approximately 7%
Congenital	—	Approximately 43–47%

In daily clinical practice, vascular causes (ischemia due to diabetes, hypertension, or arteriosclerosis) are the most common ¹². In adults, paralytic strabismus due to circulatory disorders or trauma often resolves spontaneously, but in children, except for infections, brain tumors account for most cases, so it must be treated as an emergency. In children, congenital causes are the most common, followed by trauma ¹.

Q Is oculomotor nerve palsy a rare disease?

A

It is the second most common cranial nerve palsy and is encountered in daily clinical practice. In adults, ischemic causes are the most common, and special attention is needed in elderly patients, diabetics, and hypertensive patients.

2. Main symptoms and clinical findings

Clinical photograph of oculomotor nerve palsy. Ptosis and mydriasis of one eye are seen.

Cai Y, et al. Rare oculomotor nerve palsy after interventional treatment of anterior communicating artery aneurysm: A case report. Medicine (Baltimore). 2025. Figure 4. PMCID: PMC12599633. License: CC BY.

There is ptosis of one eye, and when the eyelid is lifted, mydriasis of the affected side can be confirmed. This photograph shows typical external ocular findings in oculomotor nerve palsy.

Subjective symptoms

• Diplopia: One of the most common ocular symptoms. Often presents with sudden onset of double vision.
• Ptosis: Accounts for about 70% of initial symptoms. Complete paralysis of the levator palpebrae superioris results in complete closure of the palpebral fissure.
• Eye pain/headache: May occur as a symptom of irritation in the first division of the trigeminal nerve. In aneurysms, particularly severe headache may be present.
• Systemic neurological symptoms: Depending on the lesion site, hemiplegia, involuntary movements, or impaired consciousness may occur.

Clinical Findings

Findings differ between complete and partial palsy.

Complete Palsy

Eye position: Exotropia with mild hypotropia in primary gaze.

Eye movement: Limited adduction (does not cross midline), limited elevation, limited depression. If the trochlear nerve is intact, intorsion is observed during depression.

Eyelid: Complete ptosis.

Pupil: Dilated, with loss of direct and consensual light reflex.

Partial Palsy

Superior branch palsy: Ptosis + superior rectus palsy (limited elevation). In cavernous sinus aneurysms, superior branch palsy is more common than inferior branch palsy.

Inferior branch palsy: Presents with a combination of pupillary fiber, inferior rectus, inferior oblique, and medial rectus involvement.

Aberrant regeneration: Common after trauma or compressive lesions. Seen in 61–93% of congenital oculomotor nerve palsy.

Compensatory Head Posture

In oculomotor nerve palsy, a compensatory head posture may be adopted to avoid diplopia. If there is abduction deviation due to medial rectus palsy, the face is turned toward the affected side to maintain fusion.

Urgency of Pupillary Findings

Oculomotor nerve palsy with mydriasis strongly suggests a posterior communicating artery aneurysm (IC-PC aneurysm). Because pupillary fibers run in the most superficial layer of the nerve and are vulnerable to compression, mydriasis appears early when compressed by an aneurysm¹³. In a population-based study by Fang et al., the pupil was affected in approximately 64% of oculomotor nerve palsies due to compressive lesions, compared to only 16% in microvascular cases, making pupillary involvement an important clinical indicator for differential diagnosis². Same-day imaging (MRI/MRA, CTA) is an emergency. On the other hand, cases without mydriasis are often ischemic. However, some aneurysms do not affect the pupil, and in some cases the pupil is normal initially but dilates 3–5 days later, so follow-up is necessary even if the initial evaluation is normal¹.

Q Why is oculomotor nerve palsy with a dilated pupil (mydriasis) highly urgent?

A

The parasympathetic fibers of the oculomotor nerve (innervating the pupillary sphincter) run in the most superficial and dorsomedial layer of the nerve and are vulnerable to compression. Mydriasis suggests external compression by a posterior communicating artery aneurysm, which can rupture and cause fatal subarachnoid hemorrhage. See also the section on Causes and Risk Factors.

3. Causes and Risk Factors

• Vascular disorders (most common in daily practice): Ischemia due to diabetes, hypertension, and arteriosclerosis. Sudden onset, often noticed as double vision upon waking. Common in the elderly. Usually without mydriasis¹²⁴.
• Posterior communicating artery aneurysm (IC-PC aneurysm): The most important compressive lesion. Often presents with pupillary dilation as the first symptom. Rupture can be fatal and is a life-threatening emergency¹⁶.
• Uncal herniation: Compression of the oculomotor nerve due to transtentorial herniation from increased intracranial pressure. Most common cause is intracranial hemorrhage.
• Tumors: Lateral extension of pituitary tumors, meningiomas, etc. Approximately 11% in adults².
• Trauma: Approximately 12% in adults². Often associated with severe head injury. Aberrant regeneration is common after trauma.
• Inflammatory (Tolosa-Hunt syndrome): Painful ophthalmoplegia due to idiopathic granulomatous inflammation. Responds well to steroids⁷.
• Diabetic neuropathy: Arteriosclerotic occlusion of nutrient vessels in the cavernous sinus. Microvascular ischemia is mainly due to hyalinization of arterioles and disruption of the blood-nerve barrier causing demyelination, which is reversible with remyelination⁴. Pupillary fibers have rich collateral circulation, so mydriasis is usually absent, but not always normal. Prognosis is good, with recovery within a few months²⁴.
• Others: Sinus fungal infection, herpes zoster, giant cell arteritis, meningitis, encephalitis, collagen vascular disease, leukemia, Hodgkin lymphoma, post-neurosurgical complications, etc.

Main risk factors: diabetes, hypertension, vasculitis, infection, trauma, tumor, aneurysm.

Prevention and Daily Care

Proper control of blood pressure and blood sugar can reduce the risk of vascular oculomotor nerve palsy. Continue regular medical management.

Q What are the characteristics of diabetic oculomotor nerve palsy?

A

Oculomotor nerve palsy due to diabetic neuropathy is caused by atherosclerotic occlusion of the nutrient vessels within the cavernous sinus. Ischemia affects the interior of the nerve, but because the pupillary fibers have abundant collateral circulation, it usually does not cause mydriasis. The prognosis is good, often recovering within a few months, and treatment of diabetes is the top priority.

4. Diagnosis and Examination Methods

Diagnosis is based on clinical findings, but various tests are essential to identify the cause.

History and Ophthalmic Examination

• History: Onset pattern (sudden or gradual), presence of eye pain or headache, history of diabetes or hypertension, diurnal variation of symptoms (important for differentiating from myasthenia gravis)
• Eye movement evaluation: Limitation of movement in each direction, assessment of conjugate movements
• Levator palpebrae superioris function: Assess whether ptosis is complete or partial
• Pupillary light reflex and accommodation reflex: Presence or absence of direct and indirect light reflex loss
• Slit-lamp examination: Check for intorsion of the eye during adduction and depression to differentiate from trochlear nerve palsy

Imaging Tests

A comparison of the main imaging tests is shown below.

Test	Features / Uses
MRI (SPGR)	Thin slices (2–3 mm) with high resolution. Clearly depicts compression by IC-PC aneurysm.
MRA	Noninvasive cerebral artery visualization. Most convenient and diagnostically valuable for detecting IC-PC aneurysms.
CTA (3D-CT angiography)	Sensitivity 90% for aneurysms ≥3 mm in diameter. Can be first-line along with MRA.
DSA (Digital Subtraction Angiography)	Gold standard. Invasive but most accurate.

MRI (T1-weighted, T2-weighted, fat-suppressed, diffusion-weighted, gadolinium-enhanced) is the basic test and is more useful than CT ³.

Blood Tests / Other

• Blood tests: CBC, ESR, CRP, comprehensive metabolic panel (CMP). Add antinuclear antibody, C-ANCA, P-ANCA, ACE, β-D-glucan, etc. as needed.
• CSF analysis: Performed when cavernous sinus or skull base lesions are suspected.
• Pathological diagnosis (biopsy): May be necessary for definitive diagnosis.

Differential Diagnosis

• Myasthenia gravis: Tensilon test (edrophonium 10 mg IV in 2.5 mg increments), ice test (apply ice pack to upper eyelid for 2 minutes, positive if improvement ≥2 mm, sensitivity 80–92%), assessment of diurnal variation, anti-AChR antibodies (positive rate ≤50% in ocular type)
• Thyroid eye disease: Confirm extraocular muscle hypertrophy on CT/MRI
• Others: Orbital pseudotumor, internuclear ophthalmoplegia, chronic progressive external ophthalmoplegia (CPEO), giant cell arteritis

Q How to differentiate oculomotor nerve palsy from myasthenia gravis?

A

Myasthenia gravis is characterized by diurnal variation (worsening in the evening), and the ice test (sensitivity 80–92%) and Tensilon test are useful for differentiation. Anti-AChR antibodies have a positive rate of ≤50% in ocular type, so a negative result does not rule it out. It is also important to exclude organic lesions of the oculomotor nerve and orbit on MRI/CT.

5. Standard Treatment

Treatment of the underlying cause is the highest priority. Treatment strategies according to the cause are shown below.

Ischemic

Natural course: Improvement usually begins within 4 weeks of onset, and complete recovery is expected within 12 weeks¹². The 12-month complete recovery rate for microvascular palsy is approximately 91%, which is favorable, because demyelination due to hyalinized arterioles is reversible through remyelination⁴.

Pharmacotherapy: Oral vitamin B complex and circulation-improving drugs are given to promote recovery. Management of cardiovascular risk factors is also important⁴.

Aneurysm

Emergency management: Urgent neurosurgical treatment (clipping, coil embolization, etc.) is performed. In a report by Birchall et al., all 3 patients with posterior communicating artery aneurysms showed complete recovery of oculomotor nerve function within 1–18 days after endovascular coil embolization⁶.

Same-day imaging and urgent referral to a specialist are required.

Inflammatory (Tolosa-Hunt)

Steroid therapy: Prednisolone 50–60 mg/day for the first 3 days. Orbital pain improves dramatically within 24–72 hours, and cranial nerve palsy recovers over 2–8 weeks⁷.

Caution: Early dose reduction may cause relapse; taper gradually. Relapse occurs in up to 40% of cases⁷.

Traumatic

Observation: Recovery is relatively difficult. If no improvement after 6 months, consider surgical treatment⁵.

• Diabetic: Prioritize diabetes treatment. Prognosis is good, and recovery often occurs within a few months.
• Tumor / uncal herniation: Treat the underlying disease surgically or medically.

Management of residual deficits (symptomatic treatment)

• Prism glasses: Consider after 6 months when symptoms have stabilized⁵.
• Botulinum toxin: Chemical denervation by injection into the antagonist muscle temporarily reduces diplopia.
• Strabismus surgery: Main goal is to correct eye alignment in primary position and reading position. In complete paralysis, combine supra-maximal recession, resection, and suturing of the lateral rectus to the lateral orbital wall periosteum, nasal transposition of the superior oblique toward the medial rectus insertion, and maximal shortening of the medial rectus⁵. If aberrant regeneration is present, avoid surgery on muscles with secondary reinnervation.
• Ptosis surgery: If Bell’s phenomenon is significantly impaired, be aware of the risk of exposure keratopathy.

Precautions for steroid use

Even if Tolosa-Hunt syndrome is suspected, if infection risk (especially sinus fungal infection or malignant lymphoma) cannot be ruled out, steroids should not be used carelessly. Administering steroids for fungal infection or malignant lymphoma may temporarily suppress symptoms, but relapse upon dose reduction can worsen the prognosis.

Q How long does it take for ischemic oculomotor nerve palsy to recover?

A

In many cases, improvement begins within 4 weeks after onset, and complete recovery is expected within 12 weeks (about 3 months). Vitamin B complex and circulation-improving drugs are administered to promote recovery. If no improvement is seen after more than six months, other causes such as trauma or management of residual deficits (strabismus surgery, prism glasses) should be considered.

6. Pathophysiology and Detailed Mechanism of Onset

Anatomy of the Oculomotor Nucleus

The oculomotor nucleus is located in the tegmentum of the midbrain and has a complex nuclear structure. The innervation of each subnucleus is as follows.

• Medial rectus, inferior rectus, and inferior oblique nuclei: ipsilateral innervation
• Superior rectus nucleus: contralateral innervation (decussation site unknown)
• Levator palpebrae superioris nucleus (caudal central nucleus): single nucleus innervates both sides
• Autonomic nuclei (including Edinger-Westphal nucleus): located rostrally in the nuclear group, ipsilateral innervation

The fiber arrangement within the nucleus is rostral-caudal: most rostral are parasympathetic fibers, then inferior rectus and inferior oblique, and most caudal are levator palpebrae superioris and superior rectus. Mediolaterally, superior rectus and inferior oblique are lateral, while pupillary fibers and inferior rectus are medial.

Peripherally, pupillary fibers run in the most superficial layer of the oculomotor nerve, dorsomedially (superonasal), and are vulnerable to compression but relatively resistant to ischemia (due to rich collateral circulation). This anatomical characteristic forms the basis of the clinical rule: “compressive lesions → mydriasis, ischemic lesions → normal pupil” ¹³.

The oculomotor nerve and the posterior communicating artery run parallel in the subarachnoid space, making the nerve susceptible to compression by aneurysms. In particular, pupillary fibers are located medially among the oculomotor nerve fibers and are closest to the posterior communicating artery, so pupillary dilation often presents as an initial symptom ¹.

Syndromes by Lesion Site

Nuclear Lesion

Features: Usually causes bilateral deficits.

Unilateral nuclear palsy presents with ipsilateral oculomotor palsy + moderate bilateral ptosis + contralateral superior rectus palsy.

Fascicular Lesions (Midbrain Syndromes)

Weber syndrome: Cerebral peduncle lesion. Ipsilateral oculomotor nerve palsy + contralateral hemiplegia.

Benedikt syndrome: Red nucleus lesion. Ipsilateral oculomotor nerve palsy + contralateral involuntary movements.

Claude syndrome: Red nucleus + superior cerebellar peduncle lesion. Ipsilateral oculomotor nerve palsy + contralateral ataxia and tremor.

Nothnagel syndrome: Superior cerebellar peduncle lesion. Ipsilateral oculomotor nerve palsy + cerebellar ataxia.

Subarachnoid Space, Cavernous Sinus, and Orbital Lesions

• Subarachnoid space: Compression by posterior communicating artery aneurysm is most important. Compression due to uncal herniation also occurs. Because pupillary fibers run in the most superficial layer, mydriasis appears early ¹.
• Cavernous sinus: Combined palsy with other cranial nerves (IV, V1, VI) is common (cavernous sinus syndrome). After the oculomotor nerve divides into superior and inferior branches, branch palsy is more likely ³.
• Orbit: Accompanied by visual loss, ophthalmoplegia, and proptosis. Branch palsy is more likely ³.

---

7. References

1. Modi P, Singh J. Cranial Nerve III Palsy (Oculomotor Palsy). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. PMID: 30252368. https://www.ncbi.nlm.nih.gov/books/NBK526112/
2. Fang C, Leavitt JA, Hodge DO, Holmes JM, Mohney BG, Chen JJ. Incidence and Etiologies of Acquired Third Nerve Palsy Using a Population-Based Method. JAMA Ophthalmol. 2017;135(1):23-28. doi:10.1001/jamaophthalmol.2016.4456. PMID: 27893002. PMCID: PMC5462106.
3. Shree R, Mahesh KV, Balaini N, Goel A. Oculomotor Cranial Neuropathies: Diagnosis and Management. Ann Indian Acad Neurol. 2022;25(Suppl 2):S70-S82. doi:10.4103/aian.aian_167_22. PMID: 36589037. PMCID: PMC9795710.
4. Galtrey CM, Schon F, Nitkunan A. Microvascular Non-Arteritic Ocular Motor Nerve Palsies—What We Know and How Should We Treat? Neuroophthalmology. 2014;39(1):1-11. doi:10.3109/01658107.2014.963252. PMID: 27928323. PMCID: PMC5123092.
5. Singh A, Bahuguna C, Nagpal R, Kumar B. Surgical management of third nerve palsy. Oman J Ophthalmol. 2016;9(2):80-86. doi:10.4103/0974-620X.184509. PMID: 27433033. PMCID: PMC4932800.
6. Birchall D, Khangure MS, McAuliffe W. Resolution of third nerve paresis after endovascular management of aneurysms of the posterior communicating artery. AJNR Am J Neuroradiol. 1999;20(3):411-413. PMID: 10219405. PMCID: PMC7056059.
7. Dutta P, Anand K. Tolosa-Hunt Syndrome: A Review of Diagnostic Criteria and Unresolved Issues. J Curr Ophthalmol. 2021;33(2):104-111. doi:10.4103/joco.joco_134_20. PMID: 34409218. PMCID: PMC8365592.